Large-scale testing (Phase 3)Study completedNCT02166814
What this trial is testing
A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and Dyslipidemia
Who this might be right for
Essential Hypertension, Dyslipidemia
Boryung Pharmaceutical Co., Ltd 140